Protagonist Announces New Icotrokinra Data Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis. 31.7% of…
The Agentic Web is Here: Why NLWeb Makes Schema Your Greatest SEO Asset Microsoft's NLWeb bridges websites and AI agents, enabling smarter…
Government to Repeal Presumption of Parental Involvement The government plans to repeal the presumption of parental involvement from the C…
Rolls-Royce Successfully Tests First Pure Methanol Marine Engine Rolls-Royce has successfully tested the world's first high-speed marine e…
Intersectional Disparities in Digital Health and Mental Health Service Use Among US Youth During the COVID-19 pandemic, sexual minority yo…
Childcare Champions: Mapping Access to Essential Services The Ofsted team, led by its head, has initiated a project to identify areas with…
Assessing the Success of Salt Lake City's 'No Kings' Protest The second "No Kings" protest in Salt Lake City has concluded, and organizers…
Throwback Series: Managing Bilateral Diabetic Macular Edema David Eichenbaum, MD, FASRS, recalls a case from early in his career managing …
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology The global oncology market is rapidly shifting …
Insurance: Protecting Against AI’s Dark Side Executives face AI-driven cyber threats. Insurers, reinsurers, and corporates are navigating …